Table of Contents
| << Previous Issue | Mar 2006 (Vol: 2006, Issue: 69) | Next Issue >> |
- Section: Business Commentaries
-
Diagnose This
- Section: Cartoons
-
Biotech acquisition
- Section: Deal Trackers
-
Hirulog (bivalirudin)
- Section: Distribution & Marketing
-
Pharmaxis Reveals Marketing Strategy
- Section: Features
-
Divestments and Acquisitions: A Changing Landscape
-
Procter and Gamble: Inspiring Success
-
The Changing Face of Indian Pharma
-
Technology Focus: Influenza Diagnostics
- Section: General
-
Dealing with Litigation
-
Almirall Prodesfarma SA
- Section: Licensing
-
Affymax and Takeda to Commercialize Hematide™
-
BioCryst Collaborates in Oncology with Mundipharma
-
Elan Grants Prialt™ Rights to Eisai
- Section: Mergers & Acquisitions
-
Dr. Reddy’s Acquires betapharm to Expand European Operations
- Section: Research & Development
-
CombinatoRx and Fovea in Alliance to Treat Ophthalmic Disease
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.



RSS